SEPARATION AGREEMENT AND RELEASE OF CLAIMSSeparation Agreement • March 30th, 2004 • Nanogen Inc • Laboratory analytical instruments • California
THIS SEPARATION AND RELEASE AGREEMENT (the “Agreement”), dated May 21, 2003 is entered into by GERARD A. WILLS (“Executive”) and NANOGEN, INC., a Delaware corporation (the “Company”).
WARRANT TO PURCHASE COMMON STOCK OF NANOGEN, INC. Expires June 6, 2008Warrant Agreement • March 30th, 2004 • Nanogen Inc • Laboratory analytical instruments • California
THIS CERTIFIES THAT, for value received, Aventis Pharma Deutschland GmbH, a German limited liability company (“Aventis”) or its registered assigns (Aventis or its registered assigns shall hereinafter be referred to as “Holder”), is entitled, subject to the terms and conditions set forth below, to subscribe for and purchase up to 323,850 shares (as adjusted pursuant to the provisions hereof, the “Shares”) of the fully paid and nonassessable common stock (“Common Stock”), par value $.001 per share, of Nanogen, Inc., a Delaware corporation (the “Company”) at an exercise price per share of $5.618 (such price and such other price as shall result, from time to time, from adjustments specified herein is referred to as the “Exercise Price”). The term “Warrant” as used herein shall mean this Warrant, and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is being issued pursuant to the Cooperation and Shareholders’ Agreement among Aventis Research and T
